Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Daily pill daraxonrasib doubles survival time for pancreatic cancer patients

  • Posted on June 1, 2026
  • By BBC News
  • 0 Views
  • 1 min read
Daily pill daraxonrasib doubles survival time for pancreatic cancer patients
Daily pill daraxonrasib doubles survival time for pancreatic cancer patients

The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.
continue reading...

Author
BBC News

You May Also Like